[Methoxypropriocin in the treatment of degenerative bone disease (comparative studies)].
D001241:Aspirin / Q000627:therapeutic use; D001591:Benzydamine / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D009280:Naphthaleneacetic Acids / Q000627:therapeutic use*; D009288:Naproxen / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
D009280:Naphthaleneacetic Acids; D001591:Benzydamine; D009288:Naproxen; D001241:Aspirin; D007213:Indomethacin
Metoksypropriocyn w leczeniu choroby zwyrodnieniowej kości (badania porównawcze)